Eisai To Produce Antibody Testing Agents In U.S. For FY2013 Trials
This article was originally published in PharmAsia News
Executive Summary
Eisai said it expects to begin U.S. production of antibody testing agents to be used in fiscal 2013 trials, beginning with producing supplies for as many as seven trials a year.